SOUTHERN MEDICAL JOURNAL, vol.100, no.1, pp.27-32, 2007 (SCI-Expanded)
Objective: Capecitabine exerts considerable therapeutic efficacy in metastatic breast cancer (MBC) patients previously treated with anthracyclines and taxanes.